TUM Klinikum

Futó vizsgálatok

• Még nem toboroz

  Post-intervention dual antiplatelet therapy for mild stroke

  2026-525681-22-00· 3. fázis· Technische Universitaet Dresden· Forrás

• Még nem toboroz

  Efficacy And Safety of Olatorepatide in Adults With Overweight or Obesity Without Diabetes

  NCT07896265· 3. fázis· Regeneron Pharmaceuticals· Forrás

• Toboroz

  Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease

  NCT07781657· 2. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease

  NCT07781644· 2. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  SIL204-SL Treatment for Locally Advanced Pancreatic Cancer

  2025-525157-39-00· 2/3. fázis· Silexion Therapeutics Ltd.· Forrás

• Toboroz

  Cevostamab in Combination With Pomalidomide and Dexamethasone After BCMA- Targeting CAR T-Cell Therapy in Participants With Previously Treated Multiple Myeloma

  NCT07825064· 2. fázis· Hoffmann-La Roche· Forrás

• Még nem toboroz

  A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis

  NCT07873801· 3. fázis· Almirall, S.A.· Forrás

• Még nem toboroz

  A trial to learn how well AZD0120 works and about its safety in adults with transplant eligible newly diagnosed multiple myeloma.

  2026-525367-40-00· 3. fázis· AstraZeneca AB· Forrás

• Toboroz

  A clinical trial to assess the efficacy and safety of ontunisertib compared to placebo in patients with fibrostenosing Crohn’s disease

  2026-525197-19-00· 2. fázis· Agomab Spain S.L.U.· Forrás

• Toboroz

  Phase 3 Study of Investigator Choice of Chemotherapy with or without Zoldonrasib as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma

  2025-524928-21-00· 3. fázis· Revolution Medicines Inc.· Forrás

• Toboroz

  Resistance Training to Prevent Muscle Loss During Treatment With Tirzepatide

  NCT07777575· 4. fázis· Technical University of Munich· Forrás

• Még nem toboroz

  Phase 3 Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC 6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma

  2025-524969-24-00· 3. fázis· Revolution Medicines Inc.· Forrás

• Toboroz

  Reduction of SystemiC Inflammation After Ischemic Stroke by Intravenous DNase Administration (ReSCInD)

  NCT05880524· 2. fázis· Ludwig-Maximilians - University of Munich· Forrás

• Még nem toboroz

  A study of benfo‑oxythiamine added to Pluvicto® in adults with advanced prostate cancer whose disease is stable after two prior Pluvicto® cycles

  2026-527059-25-00· 1/2. fázis· Benfovir AG· Forrás

• Még nem toboroz

  Continuous or Intermittent Cetuximab Plus FOLFIRI as First-line Treatment in RAS/BRAF Wild-type mCRC Patients

  NCT07004413· 3. fázis· Charite University, Berlin, Germany· Forrás

• Toboroz

  A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML

  NCT07751991· 1. fázis· Charm Therapeutics· Forrás

• Még nem toboroz

  A Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies

  NCT07719348· 1/2. fázis· Servier· Forrás

• Toboroz

  Exercise Phenotyping Prior to Chemotherapy in Newly Diagnosed Multiple Myeloma (MM-Exercise)

  NCT07851493· Technical University of Munich· Forrás

• Még nem toboroz

  AIEOP-BFM ALL 2025 - International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia

  2025-522190-11-01· 3. fázis· Universitaetsklinikum Schleswig-Holstein AöR· Forrás

• Még nem toboroz

  NeoAdjuvant Therapy Comparing Sacituzumab Govitecan+Pembrolizumab vs. SoC Chemotherapy in Clinical Stage II-III, Triple-negative Early Breast Cancer

  NCT07178730· 3. fázis· Women's Cancer Study Group GmbH· Forrás

• Toboroz

  Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

  2025-524335-39-00· 3. fázis· Gilead Sciences Inc.· Forrás

• Toboroz

  FUNCtion ALS: Aiming to Restore UNC13A Function in People Living With ALS

  NCT07674667· 1/2. fázis· Trace Neuroscience, Inc.· Forrás

• Még nem toboroz

  Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer.

  2026-525883-17-00· 3. fázis· Genmab A/S· Forrás

• Toboroz

  A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

  NCT07711418· 3. fázis· Nektar Therapeutics· Forrás

• Toboroz

  Gustabor Phase 2 - Treating Taste Changes During Cancer Therapy: A Randomized Study Evaluating an AI- Based Nutrition Intervention

  NCT07649681· Wuerzburg University Hospital· Forrás

• Toboroz

  A Phase 1 Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies

  2026-525234-39-00· 1. fázis· Janssen Cilag International· Forrás

• Toboroz

  An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

  NCT07665437· 3. fázis· Novartis Pharmaceuticals· Forrás

• Még nem toboroz

  AV Nodal Ablation With Conduction System Pacing Versus Cardiac Resynchronization for Symptomatic Heart Failure Patients With Atrial Fibrillation

  NCT07604727· University Medical Center Groningen· Forrás

• Még nem toboroz

  GMMG-HD11/DSMM XXI/64007957MMY3010

  NCT07671287· 3. fázis· University of Heidelberg Medical Center· Forrás

• Toboroz

  A Randomized Phase 1 / 2 Trial Aiming to Restore UNC13A Function in People living with ALS: FUNCtion ALS

  2025-523111-11-00· 1/2. fázis· Trace Neuroscience Inc.· Forrás

• Toboroz

  A randomized double-masked, multicenter, 3 arm pivotal Phase 2/3 study to evaluate the efficacy and safety of intravitreal (IVT) EYE201/MK-8748 in participants with neovascular age-related macular degeneration (NVAMD)

  2025-524575-22-00· 2/3. fázis· Eyebiotech Limited· Forrás

• Toboroz

  A Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination with FOLFOX versus Bevacizumab in Combination with FOLFOX for the First-line Treatment of Metastatic Colorectal Cancer (HARMONi-GI3)

  2025-521587-35-00· 3. fázis· Summit Therapeutics Inc.· Forrás

• Toboroz

  PREFer

  NCT06916416· 2. fázis· University Of Cologne· Forrás

• Toboroz

  Peripheral Neuropathy in Patients Receiving Enfortumab Vedotin and Pembrolizumab as Perioperative Systemic Therapy for Urothelial Carcinoma

  NCT07870577· Comprehensive Cancer Center Munich (CCCM)· Forrás

• Még nem toboroz

  A double-blind, randomised, placebo-controlled, first-in-human (FIH) Phase I/IIa, multi-centre trial to assess safety, tolerability, and immune response of single and multiple ascending doses of TOL2 (Immune Tolerising Agent) in patients with generalised myasthenia gravis

  2024-515627-10-00· 1/2. fázis· Bonsai Biotherapeutics AB· Forrás

• Toboroz

  Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year

  2025-521590-13-00· 3. fázis· Janssen Cilag International· Forrás

• Még nem toboroz

  A trial to learn how well AZD0120 works and about its safety in adults with newly diagnosed multiple myeloma

  2025-524014-29-00· 3. fázis· AstraZeneca AB· Forrás

• Toboroz

  A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT07577856· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

  NCT07577843· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Post-Market Clinical Follow-Up (PMCF) Observational Registry (RE-PROVE)

  NCT07279649· W.L.Gore & Associates· Forrás

• Toboroz

  Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator’s Choice in Participants With Endometrial Cancer ( RAINFOL-03 )

  2024-519818-31-01· 3. fázis· Genmab A/S· Forrás

• Toboroz

  A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)

  NCT07489495· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

  NCT07293351· 1/2. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)

  NCT07282574· 2. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  Thrombolysis with Tenecteplase for Acute Ischemic Stroke in Patients taking Direct Oral Anticoagulants

  2025-521762-99-00· 3. fázis· University Medical Center Hamburg-Eppendorf· Forrás

• Toboroz

  Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

  NCT07223814· 3. fázis· Stichting Hemato-Oncologie voor Volwassenen Nederland· Forrás

• Toboroz

  A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

  NCT07222332· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

  NCT07431281· 3. fázis· AstraZeneca· Forrás

• Toboroz

  Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia

  NCT07284472· 2/3. fázis· Exciva GmbH· Forrás

• Fut, nem toboroz

  A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis

  NCT07230860· 2. fázis· Janssen Research & Development, LLC· Forrás

Showing 50 of 132.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Mielóma multiplex11 toboroz
• Akut mieloid leukémia (AML)9 toboroz
• Prosztatarák7 toboroz
• Mielodiszplasztikus szindróma (MDS)6 toboroz
• Vastagbélrák6 toboroz
• Gyermekkori daganatok5 toboroz
• Stroke (szélütés)5 toboroz
• Crohn-betegség4 toboroz
• Krónikus mieloid leukémia (CML)4 toboroz
• Máj- és epeúti rák4 toboroz
• 1-es típusú cukorbetegség3 toboroz
• Alzheimer-kór3 toboroz
• Elhízás3 toboroz
• Hasnyálmirigyrák3 toboroz
• Hólyagrák3 toboroz
• Krónikus limfoid leukémia (CLL)3 toboroz
• Parkinson-kór3 toboroz
• Tüdőrák3 toboroz
• Akut limfoid leukémia (ALL)2 toboroz
• Amiotrófiás laterálszklerózis (ALS)2 toboroz
• Atópiás dermatitisz (ekcéma)2 toboroz
• Fej-nyaki daganatok2 toboroz
• Gyomor- és nyelőcsőrák2 toboroz
• Hidradenitis suppurativa2 toboroz
• Méhtestrák2 toboroz
• Myasthenia gravis2 toboroz
• Neuroendokrin daganatok2 toboroz
• Pitvarfibrilláció2 toboroz
• Szívelégtelenség2 toboroz
• Vesedaganat2 toboroz
• Áttétes emlőrák1 toboroz
• Brain aneurysm1 toboroz
• Coeliac disease1 toboroz
• Colitis ulcerosa1 toboroz
• HIV-fertőzés1 toboroz
• Hodgkin-limfóma1 toboroz
• Időskori makuladegeneráció1 toboroz
• Krónikus gyulladásos demielinizációs polineuropátia (CIDP)1 toboroz
• Melanóma1 toboroz
• Mieloproliferatív neopláziák1 toboroz
• Pajzsmirigyrák1 toboroz
• Peripheral artery disease1 toboroz
• Petefészekrák1 toboroz
• Policisztás vesebetegség1 toboroz
• Sarcoidosis1 toboroz
• Sclerosis multiplex (SM)1 toboroz
• Spinális izomatrófia (SMA)1 toboroz
• Tripla negatív emlőrák1 toboroz
• Vitiligo1 toboroz

Lezárt vizsgálatok

• Lezárult

  A clinical trial to learn about the effects of VHB937 in people with Alzheimer's disease

  2024-516966-12-00· 2. fázis· Novartis Pharma AG· Forrás

• Lezárult

  Effects of maintenance cabozantinib+BSC versus BSC in children and AYA with osteosarcoma. ( CabOSTar )

  NCT06341712· 2. fázis· Ipsen Innovation· Forrás

• Lezárult

  Study to Evaluate Imetelstat in Patients With High-Risk MDS or AML Failing HMA-based Therapy

  NCT05583552· 2. fázis· GCP-Service International West GmbH· Forrás

• Leállították

  Immunosuppressive Treatment in Chronic Virus-Negative Inflammatory Cardiomyopathy

  NCT05570409· 2/3. fázis· LMU Klinikum· Forrás

• Lezárult

  A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

  NCT05601882· 3. fázis· AbbVie· Forrás

• Lezárult

  PEARLDIFER - A Phase II study of pemigatinib after curative local therapy in locally advanced intrahepatic cholangiocarcinoma (iCCA) harboring FGFR2 fusions/rearrangements

  NCT05565794· 2. fázis· Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH· Forrás

• Leállították

  Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma

  NCT04854499· 2. fázis· Gilead Sciences· Forrás

• Lezárult

  Study to Evaluate Adverse Events and Change in Disease Activity in Adult and Adolescent Participants With Acute Hepatitis C Virus (HCV) Infection on Treatment With Oral Tablets of Glecaprevir (GLE)/Pibrentasvir (PIB)

  NCT04903626· 3. fázis· AbbVie· Forrás

• Lezárult

  Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis

  NCT04472598· 3. fázis· AbbVie· Forrás

• Lezárult

  Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010)

  NCT03834519· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)

  NCT03615326· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  GPPAD-POInT (Global Platform of Autoimmune Diabetes - Primary Oral Insulin Trial)

  NCT03364868· 2. fázis· Technical University of Munich· Forrás

• Lezárult

  A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )

  NCT03047395· 3. fázis· AbbVie· Forrás

• Lezárult

  Standard Chemoimmunotherapy (FCR/BR) Versus Rituximab + Venetoclax (RVe) Versus Obinutuzumab (GA101) + Venetoclax (GVe) Versus Obinutuzumab + Ibrutinib + Venetoclax (GIVe) in Fit Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without Del(17p) or TP53 Mutation

  NCT02950051· 3. fázis· German CLL Study Group· Forrás

• Lezárult

  A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer

  NCT02163694· 3. fázis· AbbVie· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Osteoarthritis43 munka · 0 vizsgálat
• Hasnyálmirigyrák38 munka · 4 vizsgálat
• Koszorúér-betegség31 munka · 1 vizsgálat
• Sclerosis multiplex (SM)31 munka · 1 vizsgálat
• 1-es típusú cukorbetegség20 munka · 5 vizsgálat
• Aortic aneurysm17 munka · 0 vizsgálat
• Amiotrófiás laterálszklerózis (ALS)14 munka · 2 vizsgálat
• Fej-nyaki daganatok13 munka · 3 vizsgálat
• Neuroendokrin daganatok12 munka · 2 vizsgálat
• Neuromyelitis optica (NMOSD)11 munka · 0 vizsgálat
• Brain aneurysm11 munka · 1 vizsgálat
• Long COVID és ME/CFS9 munka · 0 vizsgálat
• Dystonia8 munka · 0 vizsgálat
• Frontotemporális demencia8 munka · 0 vizsgálat
• Duchenne-izomdisztrófia5 munka · 0 vizsgálat
• Barrett's oesophagus4 munka · 0 vizsgálat